Amedisys Balance Sheet Health
Financial Health criteria checks 6/6
Amedisys has a total shareholder equity of $1.1B and total debt of $364.0M, which brings its debt-to-equity ratio to 31.9%. Its total assets and total liabilities are $2.1B and $947.2M respectively. Amedisys's EBIT is $202.3M making its interest coverage ratio 7.4. It has cash and short-term investments of $108.2M.
Key information
31.9%
Debt to equity ratio
US$364.01m
Debt
Interest coverage ratio | 7.4x |
Cash | US$108.23m |
Equity | US$1.14b |
Total liabilities | US$947.22m |
Total assets | US$2.09b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ADY's short term assets ($526.4M) exceed its short term liabilities ($484.9M).
Long Term Liabilities: ADY's short term assets ($526.4M) exceed its long term liabilities ($462.4M).
Debt to Equity History and Analysis
Debt Level: ADY's net debt to equity ratio (22.4%) is considered satisfactory.
Reducing Debt: ADY's debt to equity ratio has reduced from 58.9% to 31.9% over the past 5 years.
Debt Coverage: ADY's debt is well covered by operating cash flow (28.8%).
Interest Coverage: ADY's interest payments on its debt are well covered by EBIT (7.4x coverage).